NCEL (NewcelX) Other Financing: $2.34 Mil (TTM As of Dec. 2025)


NCEL NewcelX Ltd NCEL
33 GF Score
Price $3.83
! 4 Warning Signs
View Full Analysis

What is NewcelX Other Financing?

NewcelX NCEL -0.52% 33 Other Financing is $2.34 Mil as of Dec. 2025. GuruFocus rates NCEL with a GF Score™ of 33/100. The stock has 4 warning signs investors should review.

NewcelX's Other Financing for the six months ended in Dec. 2025 was $2.34 Mil.

NewcelX's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was $2.34 Mil.

NewcelX Other Financing Historical Data

* Premium members only.

The historical data trend for NewcelX's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NewcelX Other Financing Chart

NewcelX Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.44 0.36 2.34

NewcelX Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.00 0.36 0.00 2.34
NCEL
33GF Score
NewcelX Ltd NCEL
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NewcelX Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $2.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $2.34 Mil mean?
NewcelX (NCEL) has a Other Financing of $2.34 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for NewcelX and its competitors.
Is NewcelX's Other Financing too high?
NewcelX's current Other Financing is $2.34 Mil. Overall, NewcelX has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does NewcelX's Other Financing compare to LPCN and PTN?
NewcelX's Other Financing of $2.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for NewcelX and its competitors. NewcelX's current Other Financing is $2.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewcelX stock overvalued right now?
NewcelX (NCEL) has a current Other Financing of $2.34 Mil. The current Other Financing is $2.34 Mil. NewcelX's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For NewcelX (NCEL), the current Other Financing is $2.34 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NewcelX Business Description

Address Hohstrasse 1, Kloten, CHE, 8302
NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.
33GF Score

Get the complete analysis for NCEL

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.83
Price